Table 2.
Baseline demographic and clinical characteristics
| Q8003 12 mg/8 mg (N = 171) | Morphine 12 mg (N = 176) | Oxycodone 8 mg (N = 175) | |
|---|---|---|---|
| Sex, N (%) | |||
| Male | 26 (15.2) | 25 (14.2) | 28 (16.0) |
| Female | 145 (84.8) | 151 (85.8) | 147 (84.0) |
| Mean (SD) Age, year | 44.3 ± 12.5 | 42.6 ± 14.0 | 44.6 ± 13.1 |
| Mean (SD) BMI (kg/m2) | 25.7 ± 4.1 | 25.4 ± 4.3 | 26.4 ± 4.4 |
| Race/ethnicity, N (%) | |||
| White | 107 (62.6) | 102 (58.0) | 99 (56.6) |
| Black | 32 (20.5) | 33 (18.8) | 49 (28.0) |
| Asian or Indian | 10 (5.8) | 9 (5.1) | 7 (4.0) |
| Other | 19 (11.1) | 32 (18.1) | 20 (11.4) |
| Hispanic or Latino | 42 (24.6) | 45 (25.6) | 34 (19.4) |
| Baseline NPRS score ≥ 7, N (%) | 89 (52.0) | 66 (37.5) | 81 (46.3) |
BMI = body mass index; NPRS = numerical pain rating scale; SD = standard deviation.